世界の低分子量ヘパリンナトリウム市場レポート2020年

QYResearchが発行した調査報告書(QYR21FB8276)
◆英語タイトル:Global Low Molecular Weight Heparin Sodium Sales Market Report 2020
◆商品コード:QYR21FB8276
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年1月(※2024年版があります。お問い合わせください。)
◆ページ数:134
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界の低分子量ヘパリンナトリウム市場について種類別(エノキサパリン、ダルテパリン、チンザパリン、フラキシパリン)、用途別(医療、研究)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・低分子量ヘパリンナトリウム市場の概要
・世界の主要地域別低分子量ヘパリンナトリウム市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の低分子量ヘパリンナトリウム市場規模2015-2026:種類別(エノキサパリン、ダルテパリン、チンザパリン、フラキシパリン)
・世界の低分子量ヘパリンナトリウム市場規模2015-2026:用途別(医療、研究)
・低分子量ヘパリンナトリウムのアメリカ市場規模2015-2020
・低分子量ヘパリンナトリウムのヨーロッパ市場規模2015-2020
・低分子量ヘパリンナトリウムの中国市場規模2015-2020
・低分子量ヘパリンナトリウムの日本市場規模2015-2020
・低分子量ヘパリンナトリウムの東南アジア市場規模2015-2020
・低分子量ヘパリンナトリウムのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・低分子量ヘパリンナトリウムの製造コスト分析
・販売チャネル、流通業者、顧客
・低分子量ヘパリンナトリウムの市場動向・機会・課題
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Low Molecular Weight Heparin Sodium Market
The global Low Molecular Weight Heparin Sodium market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Low Molecular Weight Heparin Sodium Scope and Market Size
The global Low Molecular Weight Heparin Sodium market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Low Molecular Weight Heparin Sodium market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Low Molecular Weight Heparin Sodium market is segmented into
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine

Segment by Application, the Low Molecular Weight Heparin Sodium market is segmented into
Medical
Research

The Low Molecular Weight Heparin Sodium market is analysed and market size information is provided by regions (countries). Segment by Application, the Low Molecular Weight Heparin Sodium market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Low Molecular Weight Heparin Sodium Market Share Analysis
Low Molecular Weight Heparin Sodium market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Low Molecular Weight Heparin Sodium business, the date to enter into the Low Molecular Weight Heparin Sodium market, Low Molecular Weight Heparin Sodium product introduction, recent developments, etc.

The major vendors covered:
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutica
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group

【レポートの目次】

1 Low Molecular Weight Heparin Sodium Market Overview
1.1 Low Molecular Weight Heparin Sodium Product Scope
1.2 Low Molecular Weight Heparin Sodium Segment by Type
1.2.1 Global Low Molecular Weight Heparin Sodium Sales by Type (2020-2026)
1.2.2 Enoxaparin
1.2.3 Dalteparin
1.2.4 Tinzaparin
1.2.5 Fraxiparine
1.3 Low Molecular Weight Heparin Sodium Segment by Application
1.3.1 Global Low Molecular Weight Heparin Sodium Sales Comparison by Application (2020-2026)
1.3.2 Medical
1.3.3 Research
1.4 Low Molecular Weight Heparin Sodium Market Estimates and Forecasts (2015-2026)
1.4.1 Global Low Molecular Weight Heparin Sodium Sales Growth Rate (2015-2026)
1.4.2 Global Low Molecular Weight Heparin Sodium Revenue and Growth Rate (2015-2026)
1.4.3 Global Low Molecular Weight Heparin Sodium Price Trends (2015-2026)

2 Low Molecular Weight Heparin Sodium Estimate and Forecast by Region
2.1 Global Low Molecular Weight Heparin Sodium Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Low Molecular Weight Heparin Sodium Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Low Molecular Weight Heparin Sodium Sales Market Share by Region (2015-2020)
2.2.2 Global Low Molecular Weight Heparin Sodium Revenue Market Share by Region (2015-2020)
2.3 Global Low Molecular Weight Heparin Sodium Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Low Molecular Weight Heparin Sodium Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Low Molecular Weight Heparin Sodium Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Low Molecular Weight Heparin Sodium Estimates and Projections (2015-2026)
2.4.2 Europe Low Molecular Weight Heparin Sodium Estimates and Projections (2015-2026)
2.4.3 China Low Molecular Weight Heparin Sodium Estimates and Projections (2015-2026)
2.4.4 Japan Low Molecular Weight Heparin Sodium Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Low Molecular Weight Heparin Sodium Estimates and Projections (2015-2026)
2.4.6 India Low Molecular Weight Heparin Sodium Estimates and Projections (2015-2026)
3 Global Low Molecular Weight Heparin Sodium Competition Landscape by Players
3.1 Global Top Low Molecular Weight Heparin Sodium Players by Sales (2015-2020)
3.2 Global Top Low Molecular Weight Heparin Sodium Players by Revenue (2015-2020)
3.3 Global Low Molecular Weight Heparin Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Low Molecular Weight Heparin Sodium as of 2019)
3.4 Global Low Molecular Weight Heparin Sodium Average Price by Company (2015-2020)
3.5 Manufacturers Low Molecular Weight Heparin Sodium Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Low Molecular Weight Heparin Sodium Players (Opinion Leaders)
4 Global Low Molecular Weight Heparin Sodium Market Size by Type
4.1 Global Low Molecular Weight Heparin Sodium Historic Market Review by Type (2015-2020)
4.1.1 Global Low Molecular Weight Heparin Sodium Sales Market Share by Type (2015-2020)
4.1.2 Global Low Molecular Weight Heparin Sodium Revenue Market Share by Type (2015-2020)
4.1.3 Global Low Molecular Weight Heparin Sodium Price by Type (2015-2020)
4.2 Global Low Molecular Weight Heparin Sodium Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Low Molecular Weight Heparin Sodium Sales Forecast by Type (2021-2026)
4.2.2 Global Low Molecular Weight Heparin Sodium Revenue Forecast by Type (2021-2026)
4.2.3 Global Low Molecular Weight Heparin Sodium Price Forecast by Type (2021-2026)
5 Global Low Molecular Weight Heparin Sodium Market Size by Application
5.1 Global Low Molecular Weight Heparin Sodium Historic Market Review by Application (2015-2020)
5.1.1 Global Low Molecular Weight Heparin Sodium Sales Market Share by Application (2015-2020)
5.1.2 Global Low Molecular Weight Heparin Sodium Revenue Market Share by Application (2015-2020)
5.1.3 Global Low Molecular Weight Heparin Sodium Price by Application (2015-2020)
5.2 Global Low Molecular Weight Heparin Sodium Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Low Molecular Weight Heparin Sodium Sales Forecast by Application (2021-2026)
5.2.2 Global Low Molecular Weight Heparin Sodium Revenue Forecast by Application (2021-2026)
5.2.3 Global Low Molecular Weight Heparin Sodium Price Forecast by Application (2021-2026)

6 United States Low Molecular Weight Heparin Sodium Market Facts & Figures
6.1 United States Low Molecular Weight Heparin Sodium Sales Market Share by Company (2015-2020)
6.2 United States Low Molecular Weight Heparin Sodium Sales Market Share by Type (2015-2020)
6.3 United States Low Molecular Weight Heparin Sodium Sales Market Share by Application (2015-2020)

7 Europe Low Molecular Weight Heparin Sodium Market Facts & Figures
7.1 Europe Low Molecular Weight Heparin Sodium Sales Market Share by Company (2015-2020)
7.2 Europe Low Molecular Weight Heparin Sodium Sales Market Share by Type (2015-2020)
7.3 Europe Low Molecular Weight Heparin Sodium Sales Market Share by Application (2015-2020)

8 China Low Molecular Weight Heparin Sodium Market Facts & Figures
8.1 China Low Molecular Weight Heparin Sodium Sales Market Share by Company (2015-2020)
8.2 China Low Molecular Weight Heparin Sodium Sales Market Share by Type (2015-2020)
8.3 China Low Molecular Weight Heparin Sodium Sales Market Share by Application (2015-2020)

9 Japan Low Molecular Weight Heparin Sodium Market Facts & Figures
9.1 Japan Low Molecular Weight Heparin Sodium Sales Market Share by Company (3015-3030)
9.2 Japan Low Molecular Weight Heparin Sodium Sales Market Share by Type (2015-2020)
9.3 Japan Low Molecular Weight Heparin Sodium Sales Market Share by Application (2015-2020)

10 Southeast Asia Low Molecular Weight Heparin Sodium Market Facts & Figures
10.1 Southeast Asia Low Molecular Weight Heparin Sodium Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Low Molecular Weight Heparin Sodium Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Low Molecular Weight Heparin Sodium Sales Market Share by Application (2015-2020)

11 India Low Molecular Weight Heparin Sodium Market Facts & Figures
11.1 India Low Molecular Weight Heparin Sodium Sales Market Share by Company (2015-2020)
11.2 India Low Molecular Weight Heparin Sodium Sales Market Share by Type (2015-2020)
11.3 India Low Molecular Weight Heparin Sodium Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Low Molecular Weight Heparin Sodium Business
12.1 Aspen
12.1.1 Aspen Corporation Information
12.1.2 Aspen Business Overview
12.1.3 Aspen Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Aspen Low Molecular Weight Heparin Sodium Products Offered
12.1.5 Aspen Recent Development
12.2 Sanofi-aventis
12.2.1 Sanofi-aventis Corporation Information
12.2.2 Sanofi-aventis Business Overview
12.2.3 Sanofi-aventis Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi-aventis Low Molecular Weight Heparin Sodium Products Offered
12.2.5 Sanofi-aventis Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Low Molecular Weight Heparin Sodium Products Offered
12.3.5 Pfizer Recent Development
12.4 Opocrin
12.4.1 Opocrin Corporation Information
12.4.2 Opocrin Business Overview
12.4.3 Opocrin Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Opocrin Low Molecular Weight Heparin Sodium Products Offered
12.4.5 Opocrin Recent Development
12.5 CSBIO
12.5.1 CSBIO Corporation Information
12.5.2 CSBIO Business Overview
12.5.3 CSBIO Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2015-2020)
12.5.4 CSBIO Low Molecular Weight Heparin Sodium Products Offered
12.5.5 CSBIO Recent Development
12.6 Dongying Tiandong Pharmaceutica
12.6.1 Dongying Tiandong Pharmaceutica Corporation Information
12.6.2 Dongying Tiandong Pharmaceutica Business Overview
12.6.3 Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Products Offered
12.6.5 Dongying Tiandong Pharmaceutica Recent Development
12.7 Changzhou Qianhong Bio-pharma
12.7.1 Changzhou Qianhong Bio-pharma Corporation Information
12.7.2 Changzhou Qianhong Bio-pharma Business Overview
12.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Products Offered
12.7.5 Changzhou Qianhong Bio-pharma Recent Development
12.8 Techdow
12.8.1 Techdow Corporation Information
12.8.2 Techdow Business Overview
12.8.3 Techdow Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Techdow Low Molecular Weight Heparin Sodium Products Offered
12.8.5 Techdow Recent Development
12.9 Yantai Dongcheng Pharmaceutical Group
12.9.1 Yantai Dongcheng Pharmaceutical Group Corporation Information
12.9.2 Yantai Dongcheng Pharmaceutical Group Business Overview
12.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Products Offered
12.9.5 Yantai Dongcheng Pharmaceutical Group Recent Development

13 Low Molecular Weight Heparin Sodium Manufacturing Cost Analysis
13.1 Low Molecular Weight Heparin Sodium Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Low Molecular Weight Heparin Sodium
13.4 Low Molecular Weight Heparin Sodium Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Low Molecular Weight Heparin Sodium Distributors List
14.3 Low Molecular Weight Heparin Sodium Customers

15 Market Dynamics
15.1 Low Molecular Weight Heparin Sodium Market Trends
15.2 Low Molecular Weight Heparin Sodium Opportunities and Drivers
15.3 Low Molecular Weight Heparin Sodium Market Challenges
15.4 Low Molecular Weight Heparin Sodium Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【掲載企業】

Aspen、Sanofi-aventis、Pfizer、Opocrin、CSBIO、Dongying Tiandong Pharmaceutica、Changzhou Qianhong Bio-pharma、Techdow、Yantai Dongcheng Pharmaceutical Group

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の低分子量ヘパリンナトリウム市場レポート2020年(Global Low Molecular Weight Heparin Sodium Sales Market Report 2020)]についてメールでお問い合わせはこちらでお願いします。